| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/27/2006 | US7067158 Preparation for the relief of disease |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/27/2006 | CA2195935C Streptococcus equi vaccine |
| 06/22/2006 | WO2006065814A1 Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation |
| 06/22/2006 | WO2006065216A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | WO2006065215A1 Novel compounds |
| 06/22/2006 | WO2006064945A1 Process for producing muscarine receptor antagonist and intermediate therefor |
| 06/22/2006 | WO2006064914A1 Neuraminidase inhibitor |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064304A1 Acid addition salts of muscarinic receptor antagonists |
| 06/22/2006 | WO2006064283A1 Pharmaceutical compounds and compositions |
| 06/22/2006 | WO2006064015A2 Diphenylurea derivatives useful as potassium channel activators |
| 06/22/2006 | WO2006063974A2 Il-15 antigen arrays and uses thereof |
| 06/22/2006 | WO2006063837A2 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 06/22/2006 | WO2006063763A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 06/22/2006 | WO2006063518A1 Multifunctional polypeptides |
| 06/22/2006 | WO2006061414A1 Methods and agents useful in treating conditions characterized by mucus hyperproduction/ hypersecretion |
| 06/22/2006 | WO2006051314A3 Guanidine derivatives as inhibitors of ddah |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135622 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/22/2006 | US20060135613 Carboxamides derivatives |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
| 06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135523 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| 06/22/2006 | US20060135521 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 06/22/2006 | US20060135520 Method of treating peripheral neuropathy |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060134208 Controlled release and taste masking oral pharmaceutical composition |
| 06/22/2006 | CA2591616A1 Diphenylurea derivatives useful as potassium channel activators |
| 06/22/2006 | CA2591406A1 Pharmaceutical compounds and compositions |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2590903A1 Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation |
| 06/22/2006 | CA2590845A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | CA2590843A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | CA2590778A1 Il-15 antigen arrays and uses thereof |
| 06/22/2006 | CA2587934A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 06/21/2006 | EP1672065A1 Protein expressed in nk cell |
| 06/21/2006 | EP1671972A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 06/21/2006 | EP1671961A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671942A1 Aerosol formulation comprising levalbuterol L-tartrate salt |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671651A1 Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1671629A1 Human beta-defensin secretion promoter |
| 06/21/2006 | EP1670742A1 Process for the preparation of roflumilast |
| 06/21/2006 | EP1670489A1 Use of xenon with hypothermia for treating neonatal asphyxia |
| 06/21/2006 | EP1670482A1 Use of ciclesonide for the treatment of respiratory diseases |
| 06/21/2006 | EP1450797B1 Benzothiazole derivatives |
| 06/21/2006 | EP1443915B1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/21/2006 | EP1406654A4 Methods for regulating bacteria |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1326595B1 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
| 06/21/2006 | EP1284952B1 Substituted chalcones as therapeutic compounds |
| 06/21/2006 | EP1282599B1 Disulfide derivatives useful for treating allergic diseases |
| 06/21/2006 | EP1267976B1 Microencapsulated fragrances and methods of coating microcapsules |
| 06/21/2006 | EP1267866B1 The treatment of respiratory diseases |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | CN1791594A 2-aminoquinoline derivative |
| 06/21/2006 | CN1791577A Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists |
| 06/21/2006 | CN1791429A Composition comprising a PDE4 inhibitor and a PDE5 inhibitor |
| 06/21/2006 | CN1791428A Preventives/remedies for snore or respiratory disturbances during sleep |
| 06/21/2006 | CN1791425A C1 inhibitor with short half-life for transient treatment |
| 06/21/2006 | CN1791414A Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders |
| 06/21/2006 | CN1788789A Anti-inflammatory action of oxidation type extrasin beta-10 |
| 06/21/2006 | CN1788782A Loquat leaf extractum for nourishing lung and relieving cough |
| 06/21/2006 | CN1788764A Traditional Chinese medicine formulation for improving pulmonary fibrosis |
| 06/21/2006 | CN1788762A Medicinal plaster for treating bronchial asthma and production method thereof |
| 06/21/2006 | CN1788756A Traditional Chinese medicine formulation for stopping cough and its preparation process |
| 06/21/2006 | CN1788747A Compound licorice root medicinal preparation and preparing method thereof |
| 06/21/2006 | CN1788746A Asthma plaster for children |
| 06/21/2006 | CN1788741A Use of insect-expelling saligna injection liquid for cough and gasp catabasis drug |
| 06/21/2006 | CN1788728A Compound oral liquid and suspensoid containing brufen for treating cold |
| 06/21/2006 | CN1788727A Compound dispersion tablet containing brufen for treating cold |
| 06/21/2006 | CN1260353C Preparation method of polyvalent bacteriophage for treatment of bacterial infections |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/21/2006 | CN1260215C Antagon of endostadin receptor pyrazole carboxylic acids |
| 06/21/2006 | CN1259964C Medicine for treating and preventing chronic obstructive pulmonary disease |
| 06/21/2006 | CN1259958C External used ointment for cough and asthma and its preparation |
| 06/21/2006 | CN1259948C External-applying treating liquid for rhinitis and common cold, and its preparation method thereof |
| 06/21/2006 | CN1259938C Chinese medicine compound preparation for treating cough and its preparing method |
| 06/21/2006 | CN1259931C Soft capsule of forsythia fruit oil |
| 06/21/2006 | CN1259929C Anti-virus medicine |
| 06/21/2006 | CN1259927C Medicine composition for preventing and treating asthma and chronic bronchitis and its preparation process |
| 06/21/2006 | CN1259910C Liquid drug preparations |
| 06/21/2006 | CN1259907C Pseudoephedrine hydrochloride dripping pill |
| 06/21/2006 | CN1259906C Ambroxol hydrochloride containing hydroxypropyl beta-cyclodextrin and its preparation |
| 06/21/2006 | CN1259905C Use of Rhizoma-Curcumae-Longae element in preparing medicine for treating lung disease |